Line Plot from Scientific Research

Changes in relative tumor volumes (left), dissected tumor weights (middle), and body weight (right) of patient-derived drug-resistant cancer cells (each group, n = 10). Tumors were established in NOG mice and treated with oxaliplatin, sorafenib, caloxin, and candidate 13, each agent treated alone or in combination with oxaliplatin or sorafenib, and caloxin or candidate 13. Data are presented as means SEM. * P < 0.05 vs. control, ** P < 0.01 vs. control, # P < 0.05 vs. oxaliplatin or sorafenib, ## P < 0.01 vs. oxaliplatin or sorafenib

DOI